Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alkem Laboratories Limited
ALKEM | NSE
5,696.50
INR54.50
0.97%
ALKEM | NSE
Loading StockChartView...
About Alkem Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
21/04/2026
Close
5,696.50
Open
5,664.00
High
5,718.50
Low
5,627.00
Alkem Laboratories Limited a pharmaceutical company engages in the development manufacture and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics generic drugs active pharmaceutical ingredients biosimilars and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective dermatology cardiac respiratory gastro-intestinal central nervous system oncology urology and gynaecology as well as vitamins minerals and nutrients; and pain analgesic anti-diabetic and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai India.
View LessALKEM | NSE
Risk
27.7
Sharpe
0.62
Luna's Score
70/100
Recommendation
Buy
Luna says (ALKEM | NSE)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Midcap (2B - 10B USD)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
25.4%1 month
27.7%3 months
29.0%6 months
23.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
35.71
Fwd. PE
33.11
Price to book
6.98
Debt to equity
0.14
Debt to assets
0.09
Ent. to EBITDA
25.69
Ent. to rev.
5.53
PEG
-
Other Fundamentals
EBITDA
24.36B
MarketCap
681.10B
MarketCap(USD)
7.29B
Div. yield
0.16
Op. margin
17.42
Erngs. growth
90.20
Rev. growth
2.20
Ret. on equity
17.98
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
576.50
Range1M
643.50
Range3M
840.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.08
Price X volume
726.55M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 25.69 | 24.85 | Par |
| Ent. to Revenue | 5.53 | 11.40 | Cheaper |
| PE Ratio | 35.71 | 51.36 | Cheaper |
| Price to Book | 6.98 | 6.83 | Par |
| Dividend Yield | 0.16 | 0.52 | Poor |
| Std. Deviation (3M) | 28.99 | 42.17 | Lower Risk |
| Debt to Equity | 0.14 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 681.10B | 290.82B | Market Leader |
